These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33741703)

  • 41. [Continuous Glucose Monitoring. Which is the evidence in Children?].
    Suárez-Ayala DV; Forero-Ronderos C; Coll M; Duran P; Cespedes C
    Andes Pediatr; 2021 Aug; 92(4):617-625. PubMed ID: 34652382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.
    Mauras N; Beck R; Xing D; Ruedy K; Buckingham B; Tansey M; White NH; Weinzimer SA; Tamborlane W; Kollman C;
    Diabetes Care; 2012 Feb; 35(2):204-10. PubMed ID: 22210571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections.
    McAuley SA; Vogrin S; Lee MH; Paldus B; Trawley S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Jenkins AJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Ward GM; Jones TW; O'Neal DN;
    Diabetes Technol Ther; 2021 Jun; 23(6):460-466. PubMed ID: 33351699
    [No Abstract]   [Full Text] [Related]  

  • 44. Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
    Brøsen JMB; Agesen RM; Alibegovic AC; Ullits Andersen H; Beck-Nielsen H; Gustenhoff P; Krarup Hansen T; Hedetoft CGR; Jensen TJ; Stolberg CR; Bogh Juhl C; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2022 Sep; 24(9):643-654. PubMed ID: 35467938
    [No Abstract]   [Full Text] [Related]  

  • 45. Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 Diabetes.
    Jensen MH; Cichosz SL; Hirsch IB; Vestergaard P; Hejlesen O; Seto E
    J Diabetes Sci Technol; 2021 Jul; 15(4):827-832. PubMed ID: 32456531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial.
    Little SA; Speight J; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Lubina-Solomon A; Chadwick TJ; Stocken DD; Brennand C; Marshall SM; Wood R; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
    Diabetes Care; 2018 Aug; 41(8):1600-1607. PubMed ID: 29661916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.
    Kusunoki Y; Katsuno T; Nakae R; Watanabe K; Akagami T; Ochi F; Tokuda M; Murai K; Miuchi M; Miyagawa J; Namba M
    Diabetes Res Clin Pract; 2015 May; 108(2):342-9. PubMed ID: 25779865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes.
    Stewart ZA; Thomson L; Murphy HR; Beardsall K
    Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
    Ehrhardt NM; Chellappa M; Walker MS; Fonda SJ; Vigersky RA
    J Diabetes Sci Technol; 2011 May; 5(3):668-75. PubMed ID: 21722581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
    Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
    BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
    Raviteja KV; Kumar R; Dayal D; Sachdeva N
    Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy.
    Frank JR; Blissett D; Hellmund R; Virdi N
    Diabetes Technol Ther; 2021 Sep; 23(S3):S36-S44. PubMed ID: 34546079
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinically Serious Hypoglycemia Is Rare and Not Associated With Time-in-range in Youth With New-onset Type 1 Diabetes.
    Addala A; Zaharieva DP; Gu AJ; Prahalad P; Scheinker D; Buckingham B; Hood KK; Maahs DM
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3239-3247. PubMed ID: 34265059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
    Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
    BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How use of continuous glucose monitoring can address therapeutic inertia in primary care.
    Martens TW; Parkin CG
    Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study.
    Vloemans AF; van Beers CAJ; de Wit M; Cleijne W; Rondags SM; Geelhoed-Duijvestijn PH; Kramer MHH; Serné EH; Snoek FJ
    Diabet Med; 2017 Oct; 34(10):1470-1476. PubMed ID: 28731509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
    Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?
    Beck RW; Bergenstal RM
    Diabetes Technol Ther; 2022 Mar; 24(3):153-156. PubMed ID: 34569811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.